Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

INTRODUCTION: Immune checkpoint inhibitors (ICI) are associated with unique immune-related adverse events (irAEs). Immune-related thrombocytopenia (irTCP) is an understudied and poorly understood toxicity; little data are available regarding either risk of irTCP or the effect of irTCP on clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Tyler C., Zhao, Songzhu, Li, Mingjia, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Lopez, Gabriella, Miah, Abdul, Wei, Lai, Tinoco, Gabriel, Riesenberg, Brian, Li, Zihai, Meara, Alexa, Bertino, Erin M., Kendra, Kari, Otterson, Gregory, Presley, Carolyn J., Owen, Dwight H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015999/
https://www.ncbi.nlm.nih.gov/pubmed/34618180
http://dx.doi.org/10.1007/s00262-021-03068-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015999/
https://www.ncbi.nlm.nih.gov/pubmed/34618180
http://dx.doi.org/10.1007/s00262-021-03068-2

Ejemplares similares